| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32,1 M € | -5.4% | 33,9 M € | +2.5% | 33,1 M € | +22.7% | 27,0 M € | -0.7% | 27,2 M € | +0.4% | 27,0 M € | -3.2% | 27,9 M € | +3.5% | 27,0 M € | +2.4% | 26,3 M € | -1.2% | 26,7 M € | +3.2% | 25,8 M € | -7.5% | 27,9 M € | +13.5% | 24,6 M € | +25.8% | 19,6 M € | +3.6% | 18,9 M € | +4.6% | 18,1 M € | +10.5% | 16,4 M € | |
| EBITDA | 815,1 k € | -6.0% | 867,0 k € | -13.9% | 1,0 M € | +644.3% | 135,3 k € | -73.5% | 509,5 k € | -71.8% | 1,8 M € | +59.1% | 1,1 M € | +29.7% | 876,2 k € | +46.2% | 599,2 k € | -20.9% | 757,1 k € | +35.4% | 559,0 k € | -69.7% | 1,8 M € | +42.8% | 1,3 M € | -60.0% | 3,2 M € | +5.0% | 3,1 M € | +4.7% | 2,9 M € | +7.0% | 2,7 M € | |
| Operating profit | 798,7 k € | -5.6% | 845,9 k € | -13.2% | 974,0 k € | +1047.3% | 84,9 k € | -87.2% | 664,6 k € | -61.5% | 1,7 M € | +75.5% | 983,2 k € | +21.4% | 810,2 k € | +48.3% | 546,5 k € | -22.5% | 704,7 k € | +46.7% | 480,3 k € | -72.5% | 1,7 M € | +46.5% | 1,2 M € | -62.9% | 3,2 M € | +5.0% | 3,1 M € | +3.9% | 2,9 M € | +8.5% | 2,7 M € | |
| Profit/loss | 615,4 k € | -10.1% | 684,3 k € | -13.8% | 793,4 k € | +573.3% | -167,6 k € | -140.6% | 413,2 k € | -64.5% | 1,2 M € | +73.3% | 672,0 k € | +49.2% | 450,5 k € | +9.1% | 413,0 k € | -29.2% | 583,6 k € | +24.2% | 469,8 k € | -60.0% | 1,2 M € | +38.9% | 845,1 k € | -62.6% | 2,3 M € | -20.0% | 2,8 M € | -7.6% | 3,1 M € | +50.9% | 2,0 M € | |
| Equity | 9,9 M € | +6.6% | 9,3 M € | +7.9% | 8,6 M € | +10.1% | 7,8 M € | -2.1% | 8,0 M € | -56.0% | 18,2 M € | +6.8% | 17,0 M € | +4.1% | 16,4 M € | +2.8% | 15,9 M € | +2.7% | 15,5 M € | +3.9% | 14,9 M € | +3.2% | 14,5 M € | +8.8% | 13,3 M € | +13.9% | 11,7 M € | +24.0% | 9,4 M € | +43.0% | 6,6 M € | +86.9% | 3,5 M € | |
| Total assets | 15,1 M € | +23.9% | 12,1 M € | -30.5% | 17,5 M € | -8.4% | 19,1 M € | -8.1% | 20,7 M € | -20.2% | 26,0 M € | -8.5% | 28,4 M € | +7.1% | 26,5 M € | +6.7% | 24,8 M € | +5.8% | 23,5 M € | +7.3% | 21,9 M € | -13.1% | 25,2 M € | +19.8% | 21,0 M € | +13.1% | 18,6 M € | +12.1% | 16,6 M € | +24.1% | 13,4 M € | +46.5% | 9,1 M € | |
| Cash | — | — | — | 0,0 € | -100.0% | 2,9 k € | — | 764,6 k € | +39.5% | 548,1 k € | -43.0% | 960,9 k € | +37.6% | 698,2 k € | -42.1% | 1,2 M € | -66.1% | 3,6 M € | +9010.7% | 39,0 k € | +475.9% | 6,8 k € | -97.8% | 308,5 k € | -89.6% | 3,0 M € | +148694.0% | 2,0 k € | ||||||
| Debts | 5,1 M € | +85.8% | 2,7 M € | -69.0% | 8,8 M € | -21.3% | 11,2 M € | -11.8% | 12,7 M € | +96.3% | 6,4 M € | -34.6% | 9,9 M € | +11.0% | 8,9 M € | +7.0% | 8,3 M € | +12.7% | 7,4 M € | +10.8% | 6,6 M € | -34.5% | 10,1 M € | +43.7% | 7,1 M € | +4.8% | 6,7 M € | +0.6% | 6,7 M € | +4.8% | 6,4 M € | +32.5% | 4,8 M € | |
| Staff | 21,7 | 25 | 26,8 | 32,8 | 33,1 | 30,9 | 27,4 | 27,9 | 27,8 | 30,8 | 32,5 | 40,5 | 42,8 | 25,5 | 27,3 | 35,2 | 31 | |||||||||||||||||
Public limited company · Lier · incorporated on 01/04/1967 · 21,7 ETP
Public limited company profitable and well capitalised. Cash position declining (-100.0%).
Solid counterparty for a standard engagement.
Leo Pharma is a Public limited company incorporated in 1967. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Lier. It employs on average 21,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette